Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | REN | P00797 | 14/20 | 0.67 |
| ▸ | KCNH2 | Q12809 | 13/20 | 0.67 |
| ▸ | CYP3A4 | P08684 | 12/20 | 0.67 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | NR1H4 | Q96RI1 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL555815 | 0.89 | REN (0.61) | RENKCNH2CYP3A4RAB9A | |
| SCHEMBL3719090 | 0.87 | REN (0.68) | RENKCNH2CYP3A4 | |
| SCHEMBL533832 | 0.84 | REN (0.54) | RENKCNH2CYP3A4NR1H4 | |
| SCHEMBL555742 | 0.83 | REN (0.62) | RENKCNH2CYP3A4 | |
| SCHEMBL557187 | 0.80 | REN (1.00) | RENKCNH2CYP3A4 | |
| SCHEMBL555816 | 0.80 | REN (0.56) | RENKCNH2CYP3A4RAB9ANR1H4 | |
| SCHEMBL557036 | 0.80 | REN (0.60) | RENKCNH2CYP3A4NR1H4 | |
| SCHEMBL556026 | 0.79 | REN (0.56) | RENKCNH2CYP3A4 | |
| SCHEMBL557228 | 0.78 | REN (0.53) | RENKCNH2CYP3A4 | |
| SCHEMBL556767 | 0.78 | REN (0.48) | RENKCNH2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2413941-A1 | RENIN INHIBITORS | Merck Sharp & Dohme Corp. (US) | 2012-02-08 | — | — | EP | disclosed |
| WO-2010114978-A1 | RENIN INHIBITORS | MERCK SHARP & DOHME CORP. (US) | 2010-10-07 | — | — | WO | disclosed |